Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of Enterogermina plus Oral Rehydration Therapy vs Oral Rehydration Therapy Alone in Pediatric Acute Diarrhea
2014-004636-19Phase 3
- Sponsor
- Sanofi
- Start
- Apr 2015
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of bacillus clausii in acute diarrhea (2 arms), sponsored by Sanofi. Primary endpoint: Duration of diarrhea.
02
Drugs
bacillus clausii
03
Conditions
acute diarrhea
Beyond the preview
Go deeper on 2014-004636-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004636-19.